 CAMBRIDGE, Mass.--BUSINESS WIRE--- ALVR celltherapy--AlloVir Nasdaq: ALVR, a late clinical-stage cell therapy company, announced that it will present three oral presentations and one poster presentation during the Transplantation Cellular Therapy Meeting of the American Society for Transplantation and Cellular Therapy ASTCT and the Center for International Blood Marrow Transplant Research CIBMTR taking place virtually February 8 12, 2021. Details of the oral presentations are as follows: Pres 